An observational study in Pancytopenia, sponsored by Assiut University. Status unknown. Open to participants aged 4 Weeks to 18 Years. Per ClinicalTrials.gov, last updated 2018-05-11.
Sponsored by Assiut University · Observational
Pancytopenia is an important hematologic Problem.it is a decrease in all three cellular elements of peripheral blood leading to aneamia, leucopenia and thrombocytopenia.
Pancytopenia usually presents with symptoms of bone marrow failure such as pallor, dysnea, brusing and increased tendency to infections.
The incidence of various disorders causing pancytopenia varies according to Geographical distribution and genetic mutations. It can result from :
Pancytopenia is not a disease entity but a triad of findings that may result from primary or secondary bone marrow involvement.
Bone marrow aspiration and biopsy evaluation along with clinical correlation are important to evaluate the causes of pancytopenia and plan further investigations and treatment.
Pancytopenia can result from damage to bone marrow evidanced by low reticulocyte count, or increased destruction of the peripheral blood with increased reticulocyte count.
Bone marrow examination is a simple and safe invasive procedure for evaluating the causes of pancytopenia.
The hypoplastic marrow which occurs in 2% of pediatrics acute lymphoblastic leukemia may be misdiagnosed as aplastic aneamia.
Studies done have shown leukemia to be the second most common cause of pancytopenia in pediatrics, marginally behind aplastic aneamia.
22 studies on the registry are indexed under Pancytopenia; 4 are open to participants now.
Browse Pancytopenia studies →Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Childrens and adolescents from age one month up to 18 years old suffering from pancytopenia.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Diagnostic Test: Complete blood picture
Iaboratory investigation
Availability
Bone marrow examination for all cases \[evaluate the causes of pancytopenia and plan further investigations and treatment.\]
Time frame: One year
Modification
Guidelines for management of pancytopenia modified or not? \[Strategy of blood elements transfusion in treatment\]
Time frame: One year
No study locations are listed for this record.
Plan to share: Undecided
This study is status unknown, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.